Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

November 2009; Volume 76,Issue 5

MINIREVIEW

  • You have access
    Adenylyl Cyclase–A-kinase Anchoring Protein Complexes: The Next Dimension in cAMP Signaling
    Carmen W. Dessauer
    Molecular Pharmacology November 2009, 76 (5) 935-941; DOI: https://doi.org/10.1124/mol.109.059345

Perspective

  • You have access
    An Ion Channel Hypothesis to Explain Divergent Cardiovascular Safety of Cyclooxygenase-2 Inhibitors: The Answer to a Hotly Debated Puzzle?
    Mark S. Shapiro
    Molecular Pharmacology November 2009, 76 (5) 942-945; DOI: https://doi.org/10.1124/mol.109.059683

Articles

  • You have access
    Identification of Compounds that Correlate with ABCG2 Transporter Function in the National Cancer Institute Anticancer Drug Screen
    John F. Deeken, Robert W. Robey, Suneet Shukla, Kenneth Steadman, Arup R. Chakraborty, Balasubramanian Poonkuzhali, Erin G. Schuetz, Susan Holbeck, Suresh V. Ambudkar and Susan E. Bates
    Molecular Pharmacology November 2009, 76 (5) 946-956; DOI: https://doi.org/10.1124/mol.109.056192
  • You have access
    Targeting of the Akt-Nuclear Factor-κB Signaling Network by [1-(4-Chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol (OSU-A9), a Novel Indole-3-Carbinol Derivative, in a Mouse Model of Hepatocellular Carcinoma
    Hany A. Omar, Aaron M. Sargeant, Jing-Ru Weng, Dasheng Wang, Samuel K. Kulp, Tushar Patel and Ching-Shih Chen
    Molecular Pharmacology November 2009, 76 (5) 957-968; DOI: https://doi.org/10.1124/mol.109.058180
  • You have access
    Potential Use of Cetrimonium Bromide as an Apoptosis-Promoting Anticancer Agent for Head and Neck Cancer
    Emma Ito, Kenneth W. Yip, David Katz, Sonali B. Fonseca, David W. Hedley, Sue Chow, G. Wei Xu, Tabitha E. Wood, Carlo Bastianutto, Aaron D. Schimmer, Shana O. Kelley and Fei-Fei Liu
    Molecular Pharmacology November 2009, 76 (5) 969-983; DOI: https://doi.org/10.1124/mol.109.055277
  • You have access
    Plasma Membrane Nucleolin Is a Receptor for the Anticancer Aptamer AS1411 in MV4-11 Leukemia Cells
    Sridharan Soundararajan, Li Wang, Vijayalakshmi Sridharan, Weiwei Chen, Nigel Courtenay-Luck, David Jones, Eleanor K. Spicer and Daniel J. Fernandes
    Molecular Pharmacology November 2009, 76 (5) 984-991; DOI: https://doi.org/10.1124/mol.109.055947
  • You have access
    Altered G-Protein Coupling in an mGluR6 Point Mutant Associated with Congenital Stationary Night Blindness
    Donald Beqollari, Matthew J. Betzenhauser and Paul J. Kammermeier
    Molecular Pharmacology November 2009, 76 (5) 992-997; DOI: https://doi.org/10.1124/mol.109.058628
  • You have access
    Bid and Calpains Cooperate to Trigger Oxaliplatin-Induced Apoptosis of Cervical Carcinoma HeLa Cells
    Sergio Anguissola, Barbara Köhler, Robert O'Byrne, Heiko Düssmann, Mary D. Cannon, Frank E. Murray, Caoimhin G. Concannon, Markus Rehm, Donat Kögel and Jochen H. M. Prehn
    Molecular Pharmacology November 2009, 76 (5) 998-1010; DOI: https://doi.org/10.1124/mol.109.058156
  • You have access
    tert-Butylphenylacetylene Is a Potent Mechanism-Based Inactivator of Cytochrome P450 2B4: Inhibition of Cytochrome P450 Catalysis by Steric Hindrance
    Haoming Zhang, Hsia-lien Lin, Vyvyca J. Walker, Djemel Hamdane and Paul F. Hollenberg
    Molecular Pharmacology November 2009, 76 (5) 1011-1018; DOI: https://doi.org/10.1124/mol.109.059808
  • You have access
    Interactions of Histamine H1-Receptor Agonists and Antagonists with the Human Histamine H4-Receptor
    Karl-Friedrich Deml, Silke Beermann, Detlef Neumann, Andrea Strasser and Roland Seifert
    Molecular Pharmacology November 2009, 76 (5) 1019-1030; DOI: https://doi.org/10.1124/mol.109.058651
  • You have access
    Functional Characterization of Human Cytochrome P450 2S1 Using a Synthetic Gene-Expressed Protein in Escherichia coli
    Peter H. Bui and Oliver Hankinson
    Molecular Pharmacology November 2009, 76 (5) 1031-1043; DOI: https://doi.org/10.1124/mol.109.057752
  • You have access
    Fatty Acid Hydroperoxides Support Cytochrome P450 2S1-Mediated Bioactivation of Benzo[a]pyrene-7,8-dihydrodiol
    Peter H. Bui, Erin L. Hsu and Oliver Hankinson
    Molecular Pharmacology November 2009, 76 (5) 1044-1052; DOI: https://doi.org/10.1124/mol.109.057760
  • You have access
    Differential Effects of Selective Cyclooxygenase-2 Inhibitors on Vascular Smooth Muscle Ion Channels May Account for Differences in Cardiovascular Risk Profiles
    Lioubov I. Brueggemann, Alexander R. Mackie, Bharath K. Mani, Leanne L. Cribbs and Kenneth L. Byron
    Molecular Pharmacology November 2009, 76 (5) 1053-1061; DOI: https://doi.org/10.1124/mol.109.057844
  • You have access
    Vitamin D3 and Its Nuclear Receptor Increase the Expression and Activity of the Human Proton-Coupled Folate Transporter
    Jyrki J. Eloranta, Zoulikha M. Zaïr, Christian Hiller, Stephanie Häusler, Bruno Stieger and Gerd A. Kullak-Ublick
    Molecular Pharmacology November 2009, 76 (5) 1062-1071; DOI: https://doi.org/10.1124/mol.109.055392
  • You have access
    Three Epigenetic Drugs Up-Regulate Homeobox Gene Rhox5 in Cancer Cells through Overlapping and Distinct Molecular Mechanisms
    Qiang Li, David L. Bartlett, Michael C. Gorry, Mark E. O'Malley and Z. Sheng Guo
    Molecular Pharmacology November 2009, 76 (5) 1072-1081; DOI: https://doi.org/10.1124/mol.109.056291
  • You have access
    Caveolin-1 and Lipid Microdomains Regulate Gs Trafficking and Attenuate Gs/Adenylyl Cyclase Signaling
    John A. Allen, Jiang Z. Yu, Rahul H. Dave, Anushree Bhatnagar, Bryan L. Roth and Mark M. Rasenick
    Molecular Pharmacology November 2009, 76 (5) 1082-1093; DOI: https://doi.org/10.1124/mol.109.060160
  • You have access
    High-Throughput Screening Reveals a Small-Molecule Inhibitor of the Renal Outer Medullary Potassium Channel and Kir7.1
    L. Michelle Lewis, Gautam Bhave, Brian A. Chauder, Sreedatta Banerjee, Katharina A. Lornsen, Rey Redha, Katherine Fallen, Craig W. Lindsley, C. David Weaver and Jerod S. Denton
    Molecular Pharmacology November 2009, 76 (5) 1094-1103; DOI: https://doi.org/10.1124/mol.109.059840
  • You have access
    Regulation of the CYP3A4 and CYP3A7 Promoters by Members of the Nuclear Factor I Transcription Factor Family
    Amanda K. Riffel, Eric Schuenemann and Carrie A. Vyhlidal
    Molecular Pharmacology November 2009, 76 (5) 1104-1114; DOI: https://doi.org/10.1124/mol.109.055699
  • You have access
    Mechanisms Underlying Activation of Soluble Guanylate Cyclase by the Nitroxyl Donor Angeli's Salt
    Andreas Zeller, M. Verena Wenzl, Matteo Beretta, Heike Stessel, Michael Russwurm, Doris Koesling, Kurt Schmidt and Bernd Mayer
    Molecular Pharmacology November 2009, 76 (5) 1115-1122; DOI: https://doi.org/10.1124/mol.109.059915
  • You have access
    Protein Kinase A and B-Raf Mediate Extracellular Signal-Regulated Kinase Activation by Thyrotropin
    Lisa A. Vuchak, Oxana M. Tsygankova, Gregory V. Prendergast and Judy L. Meinkoth
    Molecular Pharmacology November 2009, 76 (5) 1123-1129; DOI: https://doi.org/10.1124/mol.109.060129
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 76 (5)
Molecular Pharmacology
Vol. 76, Issue 5
November 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • MINIREVIEW
  • Perspective
  • Articles
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics